- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials Sponsored by Fudan University
Total 219789 results
-
Fudan UniversityNot yet recruitingTriple-Negative Breast CancerChina
-
Fudan UniversityNot yet recruitingColorectal Cancer | Liver MetastasesChina
-
Fudan UniversityNot yet recruitingAdvanced Solid TumorsChina
-
Fudan UniversityNot yet recruitingTNBC - Triple-Negative Breast Cancer
-
Fudan UniversityRecruitingAdvanced Salivary Gland CarcinomaChina
-
Fudan UniversityRecruitingMusculoskeletal HealthChina
-
Fudan UniversityRecruitingNon-metastatic Colorectal Cancer | Circulating Tumor DNA MethylationChina
-
Fudan UniversityRecruitingTNBC - Triple-Negative Breast CancerChina
-
Fudan UniversityRecruitingHigh-Risk Localized Soft Tissue SarcomaChina
-
Fudan UniversityNot yet recruitingHormone Receptor-positive Advanced Breast Cancer
-
Fudan UniversityRecruitingTriple-Negative Breast CancerChina
-
Fudan UniversityRecruiting
-
Fudan UniversityRecruitingLung Adenocarcinoma | SegmentectomyChina
-
Fudan UniversityNot yet recruitingMetastatic Prostate Cancer | Castration-Sensitive Prostate CancerChina
-
Fudan UniversityNot yet recruitingProstatic Neoplasms | Prostatectomy | Prostate Biopsy
-
Fudan UniversityNot yet recruitingLocally Advanced Rectal Carcinoma | MSI-High
-
Fudan UniversityRecruiting
-
Fudan UniversityNot yet recruiting
-
Fudan UniversityRecruitingBreast Cancer | Breast Neoplasm | Breast Tumors | HER2-positive Breast Cancer | Locally Advanced Breast Cancer | HER2-negative Breast Cancer | Hormone Receptor Positive Tumor | Hormone Receptor Negative Tumor | Early-stage Breast Cancer | Triple-Negative Breast Cancer (TNBC)China
-
Fudan UniversityRecruitingIdiopathic Hypogonadotropic Hypogonadism | Luteal Phase Support | Luteal Phase DeficiencyChina
-
Fudan UniversityRecruiting
-
Fudan UniversityRecruiting
-
Fudan UniversityNot yet recruitingthe Efficacy and Safety of PD-1 Inhibitors With or Without Radiotherapy in Patients With Advanced MelanomaChina
-
Fudan UniversityNot yet recruitingGastric Cancer | MSI-H | Adjuvant Therapy | PD-1 ImmunotherapyChina
-
Fudan UniversityRecruitingEsophageal Squamous Cell CarcinomaChina
-
Fudan UniversityRecruitingLaryngeal Cancer | Hypopharyngeal CancerChina
-
Fudan UniversityNot yet recruitingNon-small Cell Lung Cancer Metastatic
-
Fudan UniversityRecruiting
-
Fudan UniversityNot yet recruitingAdvanced Rectal Cancer | Liver Metastasis | Pulmonary Metastasis | Microsatellite Stable Colorectal CarcinomaChina
-
Fudan UniversityNot yet recruitingColorectal Cancer | Liver MetastasesChina
-
Fudan UniversityNot yet recruiting
-
Fudan UniversityRecruiting
-
Fudan UniversityRecruiting
-
Fudan UniversityNot yet recruitingPTCL | CHOP | PI3Kδ Inhibitor | Parsaclisib
-
Fudan UniversityRecruitingMetastatic Colorectal CancerChina
-
Fudan UniversityRecruiting
-
Fudan UniversityRecruitingObesity | Atypical Endometrial Hyperplasia | Fertility IssuesChina
-
Fudan UniversityRecruiting
-
Fudan UniversityRecruiting
-
Fudan UniversityRecruiting
-
Fudan UniversityNot yet recruiting
-
Fudan UniversityRecruiting
-
Fudan UniversityRecruitingGastric Cancer | MetastasisChina
-
Fudan UniversityRecruitingAdvanced Hepatocellular CarcinomaChina
-
Fudan UniversityRecruitingColorectal Cancer Metastatic | Liver MetastasesChina
-
Fudan UniversityRecruitingHER2-positive, Metastatic Breast CancerChina
-
Fudan UniversityRecruiting
-
Fudan UniversityRecruitingIntrahepatic CholangiocarcinomaChina
-
Fudan UniversityRecruitingIntrahepatic CholangiocarcinomaChina
-
Fudan UniversityRecruitingLaryngeal Cancer | Laryngeal Neoplasms | Hypopharynx CancerChina